Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical pharmacokinetics of valproic acid.

Literature DB >> 6767575

Clinical pharmacokinetics of valproic acid.

R Gugler, G E von Unruh.

Abstract

Entities: Chemical

Mesh：

Substances：
Valproic Acid

Year: 1980 PMID： 6767575 DOI： 10.2165/00003088-198005010-00002

Source DB: PubMed Journal: Clin Pharmacokinet ISSN： 0312-5963 Impact factor: 6.447

× No keyword cloud information.

49 in total

1. [Pharmacodynamic properties of N-dipropylacetic acid].

Authors: H MEUNIER; G CARRAZ; Y NEUNIER; P EYMARD; M AIMARD
Journal: Therapie Date: 1963 Mar-Apr Impact factor: 2.070

2. Pharmacokinetics of drugs in patients with the nephrotic syndrome.

Authors: R Gugler; D W Shoeman; D H Huffman; J B Cohlmia; D L Azarnoff
Journal: J Clin Invest Date: 1975-06 Impact factor: 14.808

3. Metabolism of valproate sodium in rabbit, rat, dog, and man.

Authors: B Ferrandes; P Eymard
Journal: Epilepsia Date: 1977-06 Impact factor: 5.864

4. Determination of lower fatty acids, particularly the anti-epileptic dipropyl-acetic acid, in biological materials by means of micro diffusion and gas chromatography.

Authors: J W Meijer; L Hessing-Brand
Journal: Clin Chim Acta Date: 1973-01-24 Impact factor: 3.786

5. The treatment of childhood epilepsy with sodium valproate.

Authors: D Haigh; W I Forsythe
Journal: Dev Med Child Neurol Date: 1975-12 Impact factor: 5.449

6. Preliminary observations on valproic acid kinetics in patients with epilepsy.

Authors: S I Johannessen
Journal: Arzneimittelforschung Date: 1977

7. Disposition of sodium valproate in epileptic patients.

Authors: E Perucca; G Gatti; G M Frigo; A Crema; S Calzetti; D Visintini
Journal: Br J Clin Pharmacol Date: 1978-06 Impact factor: 4.335

8. Pharmacokinetics of di-n-propylacetate in epileptic patients.

Authors: F Schobben; E van der Kleijn; F J Gabreëls
Journal: Eur J Clin Pharmacol Date: 1975-02-28 Impact factor: 2.953

Review 9. Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors: R M Pinder; R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1977-02 Impact factor: 9.546

10. Excretion of valproic acid into semen of rabbits and man.

Authors: B N Swanson; R C Harland; R G Dickinson; N Gerber
Journal: Epilepsia Date: 1978-12 Impact factor: 5.864

59 in total

Review 1. Pharmacokinetics of drugs in overdose.

Authors: Y J Sue; M Shannon
Journal: Clin Pharmacokinet Date: 1992-08 Impact factor: 6.447

2. Interaction between isoniazid and valproate: a case of valproate overdosage.

Authors: A P Jonville; A S Gauchez; E Autret; C Billard; P Barbier; F Nsabiyumva; M Breteau
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

3. Functional half-life is a meaningful descriptor of steady-state pharmacokinetics of an extended-release formulation of a rapidly cleared drug : as shown by once-daily divalproex-ER.

Authors: Sandeep Dutta; Ronald C Reed
Journal: Clin Drug Investig Date: 2006 Impact factor: 2.859

Review 4. Drug interactions that matter. A critical reappraisal.

Authors: G T McInnes; M J Brodie
Journal: Drugs Date: 1988-07 Impact factor: 9.546

5. Observation of Clinically Relevant Drug Interaction in Chimeric Mice with Humanized Livers: The Case of Valproic Acid and Carbapenem Antibiotics.

Authors: Eiko Suzuki; Kumiko Koyama; Daisuke Nakai; Ryoya Goda; Hiroshi Kuga; Kan Chiba
Journal: Eur J Drug Metab Pharmacokinet Date: 2017-12 Impact factor: 2.441

Review 6. Pharmacokinetic interactions with antiepileptic drugs.

Authors: E Perucca
Journal: Clin Pharmacokinet Date: 1982 Jan-Feb Impact factor: 6.447

Review 7. Anticonvulsant drugs. An update.

Authors: M J Eadie
Journal: Drugs Date: 1984-04 Impact factor: 9.546